Published in Pharm Res on November 01, 1992
Novel orally swallowable IntelliCap(®) device to quantify regional drug absorption in human GI tract using diltiazem as model drug. AAPS PharmSciTech (2014) 1.17
Effect of altered gastric emptying and gastrointestinal motility on metformin absorption. Br J Clin Pharmacol (2000) 0.89
Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy. Int J Mol Sci (2015) 0.78
Colon-specific drug delivery systems based on cyclodextrin prodrugs: in vivo evaluation of 5-aminosalicylic acid from its cyclodextrin conjugates. World J Gastroenterol (2005) 0.75
Transit of pharmaceutical dosage forms through the small intestine. Gut (1986) 2.35
The bacterial flora in the alimentary tract of freshwater salmonid fishes. Can J Microbiol (1974) 2.20
PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. J Control Release (1999) 2.08
Chitosan as a novel nasal delivery system for vaccines. Adv Drug Deliv Rev (2001) 1.87
Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res (1994) 1.61
Evaluation of impotence in older men. West J Med (1985) 1.54
The preparation and characterization of poly(lactide-co-glycolide) microparticles. II. The entrapment of a model protein using a (water-in-oil)-in-water emulsion solvent evaporation technique. Pharm Res (1993) 1.53
Non-phagocytic uptake of intravenously injected microspheres in rat spleen: influence of particle size and hydrophilic coating. Biochem Biophys Res Commun (1991) 1.50
Nanoparticles in drug delivery. Crit Rev Ther Drug Carrier Syst (1987) 1.42
Heavy metals in some Asian medicines and cosmetics. Public Health (1979) 1.42
Physicochemical properties of parenteral fat emulsions containing 20% triglyceride; Intralipid and Ivelip. J Clin Pharm Ther (1993) 1.40
Automated conductimetric titrimeter: use in studying ionic solute-solute interactions. J Pharm Sci (1975) 1.39
The use of gamma cameras to measure the disposition and fate of iodide in the rabbit [proceedings]. Br J Pharmacol (1978) 1.38
Surface modification of poly(lactide-co-glycolide) nanospheres by biodegradable poly(lactide)-poly(ethylene glycol) copolymers. Pharm Res (1994) 1.37
Evaluation of the clearance characteristics of bioadhesive systems in humans. Int J Pharm (1999) 1.30
Chitosan as a novel nasal delivery system for peptide drugs. Pharm Res (1994) 1.30
Naproxen sodium and indomethacin in acute musculoskeletal disorders. Rheumatol Rehabil (1980) 1.24
Biodegradable microparticles as controlled release antigen delivery systems. Immunology (1991) 1.24
Innovations in avoiding particle clearance from blood by Kupffer cells: cause for reflection. Crit Rev Ther Drug Carrier Syst (1994) 1.21
Gamma scintigraphy in the evaluation of pharmaceutical dosage forms. Eur J Nucl Med (1992) 1.20
Variation in gastrointestinal transit of pharmaceutical dosage forms in healthy subjects. Pharm Res (1991) 1.20
Chitosan microspheres prepared by spray drying. Int J Pharm (1999) 1.20
Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with poloxamer 407 and poloxamine 908: in vitro characterisation and in vivo evaluation. J Control Release (2001) 1.20
Validity of the geometric mean correction in the quantification of whole bowel transit. Nucl Med Commun (1985) 1.19
Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen. Immunology (1992) 1.19
Microparticles as potentially orally active immunological adjuvants. Vaccine (1989) 1.19
The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow. FEBS Lett (1992) 1.17
Secondary hypogonadism in older men: its relation to impotence. J Clin Endocrinol Metab (1990) 1.16
Incidence and prevalence of copper deficiency following roux-en-y gastric bypass surgery. Int J Obes (Lond) (2011) 1.14
Compliance in medication by Asian immigrants. Nurs Times (1979) 1.13
Lead poisoning and traditional practices: the consequences for world health. A study in Kuwait. Public Health (1981) 1.13
Transport of nanoparticles across the rat nasal mucosa. J Drug Target (2001) 1.11
Morphine kinetics after diamorphine infusion in premature neonates. Br J Clin Pharmacol (1991) 1.09
Preparation of biodegradable, surface engineered PLGA nanospheres with enhanced lymphatic drainage and lymph node uptake. Pharm Res (1997) 1.08
Coating particles with a block co-polymer (poloxamine-908) suppresses opsonization but permits the activity of dysopsonins in the serum. Biochim Biophys Acta (1993) 1.08
Preparation of sub-100 nm human serum albumin nanospheres using a pH-coacervation method. J Drug Target (1993) 1.07
Polylactide-poly(ethylene glycol) micellar-like particles as potential drug carriers: production, colloidal properties and biological performance. J Drug Target (2001) 1.07
Intra-operative nuclear medicine in surgical practice. Nucl Med Commun (1996) 1.07
Epi-fluorescence microscopy and image analysis used to measure diffusion coefficients in gel systems. J Pharm Pharmacol (1992) 1.06
Defining the drug incorporation properties of PLA-PEG nanoparticles. Int J Pharm (2000) 1.06
Controlled release microparticles for vaccine development. Vaccine (1991) 1.06
The effect of density on the gastric emptying of single- and multiple-unit dosage forms. Pharm Res (1986) 1.04
The role of gamma-scintigraphy in oral drug delivery. Adv Drug Deliv Rev (2001) 1.04
Intranasal drug delivery by spray and drops. J Pharm Pharmacol (1985) 1.04
Drug delivery to the proximal colon. J Pharm Pharmacol (1985) 1.04
An investigation of the filtration capacity and the fate of large filtered sterically-stabilized microspheres in rat spleen. Biochim Biophys Acta (1993) 1.04
Preparation and evaluation of biodegradable polymeric systems for the intra-articular delivery of drugs. J Pharm Pharmacol (1984) 1.03
Techniques for the measurement of the rheological properties of sputum. Bull Physiopathol Respir (Nancy) (1973) 1.02
Targeting of drugs and vaccines to the gut. Pharmacol Ther (1995) 1.02
Diamorphine infusion in the preterm neonate. Arch Dis Child (1991) 1.02
A noninvasive technique for monitoring lung vascular permeability in man. Nucl Med Commun (1985) 1.02
The organ uptake of intravenously administered colloidal particles can be altered using a non-ionic surfactant (Poloxamer 338). FEBS Lett (1984) 1.00
Intranasal delivery of morphine. J Pharmacol Exp Ther (2002) 0.99
Topographical distribution of blood supply to the anal canal. Br J Surg (1999) 0.99
Structure and mucoadhesion of mussel glue protein in dilute solution. Biochemistry (1998) 0.98
Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine (1995) 0.98
A comparison of the effect of viscosity on the precorneal residence of solutions in rabbit and man. J Pharm Pharmacol (1986) 0.98
The control of protein release from poly(DL-lactide co-glycolide) microparticles by variation of the external aqueous phase surfactant in the water-in oil-in water method. J Control Release (1998) 0.97
Spreading and retention of vaginal formulations in post-menopausal women as assessed by gamma scintigraphy. Pharm Res (1997) 0.97
Postoperative limb compression in reduction of haemorrhage after varicose vein surgery. Ann R Coll Surg Engl (1993) 0.97
Sustained release chitosan microspheres prepared by novel spray drying methods. J Microencapsul (1999) 0.97
Octanol-, chloroform-, and propylene glycol dipelargonat-water partitioning of morphine-6-glucuronide and other related opiates. J Med Chem (1996) 0.96
Scientific principles in design of drug dosage formulations. Br Med J (1972) 0.96
Sugar cross-linked gelatin for controlled release: microspheres and disks. Biomaterials (1998) 0.96
Physical properties and stability of two emulsion formulations of propofol. Int J Pharm (2001) 0.95
Infection and immune response in the elderly. Ann Epidemiol (1992) 0.95
Bioadhesive starch microspheres and absorption enhancing agents act synergistically to enhance the nasal absorption of polypeptides. Int J Pharm (2001) 0.95
Comparison of nebulised aerosol deposition in the lungs of healthy adults following oral and nasal inhalation. Thorax (1993) 0.94
The in-vivo evaluation of an osmotic device (Osmet) using gamma scintigraphy. J Pharm Pharmacol (1984) 0.93
Toxicity of solubilized and colloidal amphotericin B formulations to human erythrocytes. J Pharm Pharmacol (1988) 0.93
Delivery of propellant soluble drug from a metered dose inhaler. Thorax (1991) 0.93
Quantitative assessment of the response to therapy in achalasia of the cardia. Gut (1989) 0.93
Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Lett (1994) 0.92
Characterization of colonic transit of nondisintegrating tablets in healthy subjects. Dig Dis Sci (1993) 0.92
The rheological properties of sputum. Biorheology (1969) 0.92
The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol. Vaccine (1999) 0.92
Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. J Control Release (1999) 0.92
Transdermal delivery of theophylline to premature infants using a hydrogel disc system. Br J Clin Pharmacol (1990) 0.91
New aerosol delivery system for neonatal ventilator circuits. Arch Dis Child (1992) 0.91
Beta-2-adrenoceptor agonists as inhibitors of lung vascular permeability to radiolabelled transferrin in the adult respiratory distress syndrome in man. Eur J Nucl Med (1986) 0.91
Preparation of surface-modified albumin nanospheres. Biomaterials (1997) 0.91
Impotence and aging: clinical and hormonal factors. J Am Geriatr Soc (1988) 0.91
Preparation and characterisation of rose Bengal-loaded surface-modified albumin nanoparticles. J Control Release (2001) 0.91
The effect of the nasal cycle on mucociliary clearance. Clin Otolaryngol Allied Sci (2001) 0.90
The distribution of an intranasal insulin formulation in healthy volunteers: effect of different administration techniques. J Pharm Pharmacol (1994) 0.90
The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a block copolymer--poloxamine 908. Life Sci (1987) 0.89
Albumin microspheres for intra-articular drug delivery: investigation of their retention in normal and arthritic knee joints of rabbits. J Pharm Pharmacol (1987) 0.89
Clearance characteristics of chitosan based formulations in the sheep nasal cavity. Int J Pharm (2001) 0.89
Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles. Vaccine (1993) 0.88
Lymph node localisation of biodegradable nanospheres surface modified with poloxamer and poloxamine block co-polymers. FEBS Lett (1997) 0.88
Effect of the nonionic surfactant poloxamer 338 on the fate and deposition of polystyrene microspheres following intravenous administration. J Pharm Sci (1983) 0.88
Atomic force microscopy of gastric mucin and chitosan mucoadhesive systems. Biochem J (2000) 0.88
Morphology of Golgi-impregnated neurons in hyperstriatum ventralis, pars caudalis in adult male and female canaries. J Comp Neurol (1989) 0.87